Active Pharmaceutical Ingredients/API Market Global Size, Share & Trends 2018-2025

Market and Industry Analytics

Active Pharmaceutical Ingredients/API Market Global Size, Share & Trends 2018-2025

Press Release

Active Pharmaceutical Ingredients/API Market Reports presents an in-depth assessment of the Active Pharmaceutical Ingredients/API ecosystem including market drivers, challenges, enabling technologies, vertical market opportunities, applications, key trends, standardization, spectrum availability/allocation, regulatory landscape, deployment case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies.

Free PDF Sample Brochure on Active Pharmaceutical Ingredients/API Market @ https://decisionmarketreports.com/request-sample?productID=951366

The global Active Pharmaceutical Ingredients/APImarket was valued at USD 157.87 billion in 2016 and is projected to reach USD 271.97 billion by 2025, growing at a CAGR of 6.23% from 2017 to 2025.

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. With increased investments and focus on API and its applications in R&D, the market is expected to grow at a high rate during the forecast period.

Sample Infographics:

Market Dynamics:
1. Market Drivers
1.1 Increasing Prevalence of chronic disorders
1.2 Increase cases of cancer
1.3 Technological advancements in API
1.4 Increasing geriatric population
1.5 Increasing scope of generics
1.6 Expansion of applications of biopharmaceuticals
2. Market Restraints
2.1 Unfavorable Drug pricing poilicies
2.2 Stringent regulations

Market Segmentation:
1. By Therapeutic Application:
1.1 Oncology
1.2 Cardiovascular Disease
1.3 Diabetes
1.4 Central Nervous System and Neurological Disorders
1.5 Endocrinology
1.6 Other Therapeutic Applications

2. By Type of Drug:
2.1 Prescription Drugs
2.2 Over-The-Counter Drugs
2.3 Active Pharmaceutical Ingredients Market, By Potency
2.3.1 Low to Moderate Potency Active Pharmaceutical Ingredients
2.3.2 Potent to Highly Potent Active Pharmaceutical Ingredients

3. By Type of Synthesis:
3.1 Synthetic Active Pharmaceutical Ingredients
3.1.1 Innovative Synthetic APIs
3.1.2 Generic Synthetic APIs
3.2 Biotech Active Pharmaceutical Ingredients
3.2.1 By Type
3.2.1.1 Innovative Biotech APIs
3.2.1.2 Biosimilars
3.2.2 By Product
3.2.2.1 Monoclonal Antibodies
3.2.2.2 Vaccines
3.2.2.3 Hormones and Growth Factors
3.2.2.4 Cytokines
3.2.2.5 Fusion Proteins
3.2.2.6 Therapeutic Enzymes
3.2.2.7 Blood Factors
3.2.3 By Expression System
3.2.3.1 Mammalian Expression Systems
3.2.3.2 Microbial Expression Systems
3.2.3.3 Yeast Expression Systems
3.2.3.4 Plant Expression Systems
3.2.3.5 Insect Expression Systems

4. By Type of manufacturer:
4.1 Captive Manufacturers
4.2 Merchant API Manufacturers

5. By Type:
5.1 Innovative Active Pharmaceutical Ingredients
5.2 Generic Active Pharmaceutical Ingredients

6. By Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Pfizer, Inc.
2. Novartis International AG
3. Sanofi
4. BoehringerIngelheim
5. Bristol-Myers Squibb
6. Teva Pharmaceutical Industries Ltd.
7. ELI Lilly and Company
8. Glaxosmithkline PLC
9. Merck & Co., Inc.
10. Abbvie Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Know More About Active Pharmaceutical Ingredients/API Market @ https://decisionmarketreports.com/market-reports/951366/global-active-pharmaceutical-ingredientsapi-market-3

1 INTRODUCTION OF GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY THERAPEUTIC APPLICATION:
5.1 Oncology
5.2 Cardiovascular Disease
5.3 Diabetes
5.4 Central Nervous System and Neurological Disorders
5.5 Endocrinology
5.6 Other Therapeutic Applications

6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE OF DRUG:
6.1 Prescription Drugs
6.2 Over-The-Counter Drugs
6.3 Active Pharmaceutical Ingredients Market, By Potency
6.3.1 Low to Moderate Potency Active Pharmaceutical Ingredients
6.3.2 Potent to Highly Potent Active Pharmaceutical Ingredients

7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE OF SYNTHESIS:
7.1 Synthetic Active Pharmaceutical Ingredients
7.1.1 Innovative Synthetic APIs
7.1.2 Generic Synthetic APIs
7.2 Biotech Active Pharmaceutical Ingredients
7.2.1 By Type
7.2.1.1 Innovative Biotech APIs
7.2.1.2 Biosimilars
7.2.2 By Product
7.2.2.1 Monoclonal Antibodies
7.2.2.2 Vaccines
7.2.2.3 Hormones and Growth Factors
7.2.2.4 Cytokines
7.2.2.5 Fusion Proteins
7.2.2.6 Therapeutic Enzymes
7.2.2.7 Blood Factors
7.2.3 By Expression System
7.2.3.1 Mammalian Expression Systems
7.2.3.2 Microbial Expression Systems
7.2.3.3 Yeast Expression Systems
7.2.3.4 Plant Expression Systems
7.2.3.5 Insect Expression Systems

8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE OF MANUFACTURER:
8.1 Captive Manufacturers
8.2 Merchant API Manufacturers

9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/API MARKET, BY TYPE:
9.1 Innovative Active Pharmaceutical Ingredients
9.2 Generic Active Pharmaceutical Ingredients

10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012–2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012–2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012–2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012–2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 – 2025

11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS/APIMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Pfizer, Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Novartis International AG
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Sanofi
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 BoehringerIngelheim
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 Bristol-Myers Squibb
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 ELI Lilly and Company
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Glaxosmithkline PLC
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Merck & Co., Inc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Development

12.10 Abbvie Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Development

13 Appendix
13.1 Related Reports

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA

US Toll Free +18666051052
Email: [email protected]
Web: http://decisionmarketreports.com/

Tags: , , , , ,